Exhaled breath condensate eicosanoids as markers of asthma severity

W. Piotrowski, A. Antczak, J. Marczak, Z. Kurmanowska, A. Rutko, P. Górski (Lodz, Poland)

Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Session: Understanding the mechanisms and the impact of severe asthma
Session type: Oral Presentation
Number: 2977
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Piotrowski, A. Antczak, J. Marczak, Z. Kurmanowska, A. Rutko, P. Górski (Lodz, Poland). Exhaled breath condensate eicosanoids as markers of asthma severity. Eur Respir J 2008; 32: Suppl. 52, 2977

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exhaled breath condensate for evaluation of inflammation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006

Leukotrienes in exhaled breath condensate in childhood asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 398s
Year: 2003

Cytokines in exhaled breath condensate of patients with asthma
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008

Profile of prostanoids in exhaled breath condensate in childhood asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 400s
Year: 2003

Leukotrienes in exhaled breath condensate of children with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 39s
Year: 2001

Inflammatory markers in exhaled breath condensate of two COPD phenotypes
Source: Eur Respir J 2005; 26: Suppl. 49, 260s
Year: 2005

Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008


Inflammatory markers in exhaled breath condensate in bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 707s
Year: 2004

Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008


8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Exhaled bronchial NO and cysteinyl-leukotrienes in breath condensate in atopic children
Source: Eur Respir J 2002; 20: Suppl. 38, 412s
Year: 2002

The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010

Exhaled breath condensate: 8-isoprostane and eicosanoids
Source: Eur Respir Monogr 2010; 49: 196-206
Year: 2010


Exhaled breath condensates and COPD
Source: Eur Respir J 2009; 33: 1238
Year: 2009


Markers of airway diseases in exhaled breath condensate and their clinical value
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013